The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting...
Media Release SYDNEY, AUSTRALIA, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”),...
BASKING RIDGE, N.J., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
VALENCIA, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Nusano, Inc., a physics company transforming the production of medical radioisotopes, today...
SUNNYVALE, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- Eurofins Ascend Clinical announces that it has won a 2024 Structures award...
LOS ANGELES, Oct. 03, 2024 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Pink: VDRM), an innovator in transdermal drug delivery and...
Special Meeting of Stockholders Adjourned Due to Lack of QuorumSAN DIEGO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc....
• 132 patients enrolled TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Spectral Medical Inc. (“Spectral” or the “Company”) (TSX: EDT),...
TORONTO, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF)...
New 31,000 square-foot facility will enhance Legend’s leading cell therapy portfolio and expand Legend’s R&D capabilities as a global cell...
PALO ALTO, Calif., Oct. 03, 2024 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a commercial-stage...
FDA Orphan Products Grants are based on scientific and technical merit as determined by rare disease and regulatory experts Ongoing...
Toronto, Ontario--(Newsfile Corp. - October 3, 2024) - Neural Therapeutics Inc. ("Neural" or the "Company"), an ethnobotanical drug discovery company...
DATAcc is creating an open-source industry guide to address market challenges by bringing clarity on how and why to include...
DUBAI, UAE, Oct. 3, 2024 /PRNewswire/ -- XRP Healthcare is proud to announce its strategic partnership with Foventa for the...
GOTHENBURG, SE / ACCESSWIRE / October 3, 2024 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, October 3 2024 - IRLAB Therapeutics...
Organizations Plan to Jointly Advance Breakthrough Solutions in Human Health and Sustainability, Drive Research Collaboration, Entrepreneurship and Accelerate Talent Development...
Vancouver, British Columbia--(Newsfile Corp. - October 2, 2024) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or...
The First Digital Network for Research Flips the Script on Patient Recruitment PHILADELPHIA, Oct. 2, 2024 /PRNewswire/ -- Power, a...
Continuing the shift toward accelerated, sustainable growth, RXNT has acquired Scalabull, a nationwide interfacing network of laboratories and radiology facilities. Currently,...